WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: AUGUST ISSUE PUBLISHED
  • AUGUST 2024 Issue has been successfully launched on 1 AUGUST 2024.

Abstract

EVALUATION OF ANTIHYPERLIPIDEMIC ACTIVITY OF AQUEOUS EXTRACT OF BUTEA MONOSPERMA L. IN TRITON WR 1339 TREATED HYPERLIPIDEMIC RATS

P. D. Mahure, A.V. Shrirao*, M. Muqitur Rahman, V. S. Chaudhari, N. I. Kochar, A. V. Chandewar

ABSTRACT

Objective: The present work was undertaken to investigate the possible antihyperlipidemic and antioxidant effect of aqueous extract of Butea monosperma L. (BM) flowers on hyperlipidemic rats. Method: Hyperlipidemia was induced in rats by a single intraperitonial (i.p.) injection of Triton WR 1339 (400 mg/kg) and it showed sustained elevated levels of serum cholesterol and triglyceride. The Aqueous extract of Butea monosperma L. flowers (AQ-BM) (200,400 and 600 mg/kg/day) was administered to normal and hyperlipidemic rats for 14 days. Result: Serum and liver tissue were analyzed for lipid profile and antioxidants enzymes and the activity was compared to the cholesterol-lowering drug, Atorvastatin (10 mg/kg). Parameters were altered during hyperlipidemia and reverted back to near normal values after AQ-BM treatment or standard drug Atorvastatin. Lipid peroxidation decreased whereas the activities of superoxide dismutase, glutathione peroxidase and catalase increased in AQ-BM treated rats. Pronounced changes were observed at 600 mg/kg of AQ-BM for 2 weeks and it was comparable to the standard drug Atorvastatin. Conclusion: The current study provides strong evidence that AQ-BM has a remarkable beneficial effect in treating hyperlipidemia and ROS without any side effects at 600 mg/kg/day for 14 days.

Keywords: Butea monosperma L., Hyperlipidemia, Lipid profile, Antioxidant enzyme.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More